In various cancers, IFN-γ response genes and genes that encode major histocompatibility (MHC) class molecules and other antigen presentation machinery can be hypermethylated or mutated leading to reduced tumor immunogenicity (18–20). The gene discussed is IFNG; the disease is neoplasm.